Novophage takes top prize in Moot Corp Competition

Courtesy UT - Office of Public Affairs  Mon, 05/11/2009 - 10:40am

A company hoping to significantly slow the onset of antibiotic resistance has claimed the grand prize at the 26th annual Global Moot Corp Competition at the McCombs School of Business at The University of Texas at Austin.

Novophage Therapeutics from Boston University and the Massachusetts Institute of Technology beat out 39 teams from top Master of [...]



 

More related items

Shell Oil gives $313,500 in grants to university
Shell Oil Company has contributed $313,500 to support academic programs at The University of Texas at Austin. The grants benefit undergraduates and graduate students in the university's...

UT introduces program to accelerate business creation
The University of Texas at Austin has announced a campus-wide program, Texas Venture Labs, to make it easier for student and faculty entrepreneurs to start businesses by providing a faster,...

Hoover joins McCombs as entrepreneur-in-residence
Gary E. Hoover, founder of Bookstop and the company that later became Hoover's Inc., has been named entrepreneur-in-residence in the Herb Kelleher Center for Entrepreneurship at the McCombs...

New technology from Mexico to be shown at Moot Corp
A University of Texas at Austin student team has won the MSTC/CIMAV New Venture Championship and will represent Mexico in the Global Moot Corp® Competition this May. DCI Technologies won...

Photography company wins 2009 Texas Moot Corp
FocalPop, a Web-based solution for finding quality stock photography, won the Texas round of the Moot Corp® competition, the new-venture competition hosted annually at The University of...


 

Post new comment

The content of this field is kept private and will not be shown publicly.